Exosomes Derived from microRNA-27a-3p Overexpressing Mesenchymal Stem Cells Inhibit the Progression of Liver Cancer through Suppression of Golgi Membrane Protein 1

Hepatocellular carcinoma (HCC) remains a significant health burden to date. Its early diagnosis and treatment are complicated by the lack of early diagnosis markers and multidrug resistance. microRNA regulation of HCC oncogenes are among the new diagnostic and therapeutic strategies being explored,...

Full description

Saved in:
Bibliographic Details
Main Authors: Christian Cedric Bongolo, Erick Thokerunga, Qian Yan, Mohamed Bassirou Moukeila Yacouba, Chao Wang
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2022/9748714
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850173774098333696
author Christian Cedric Bongolo
Erick Thokerunga
Qian Yan
Mohamed Bassirou Moukeila Yacouba
Chao Wang
author_facet Christian Cedric Bongolo
Erick Thokerunga
Qian Yan
Mohamed Bassirou Moukeila Yacouba
Chao Wang
author_sort Christian Cedric Bongolo
collection DOAJ
description Hepatocellular carcinoma (HCC) remains a significant health burden to date. Its early diagnosis and treatment are complicated by the lack of early diagnosis markers and multidrug resistance. microRNA regulation of HCC oncogenes are among the new diagnostic and therapeutic strategies being explored, although the mode of delivery of a therapeutic dose of the miRNA remains a challenge. In this study, we explored the use of exosomes from umbilical mesenchymal stem cells transfected with miR-27a-3p to interact with the oncogene GOLM1 in HCC and inhibit HCC progression both in vitro and in vivo. We first determined and compared the expression levels of miR-27a-3p in blood, various cell lines and tissues of HCC and their corresponding normal controls. We then employed bioinformatics analysis to determine the gene target for miR-27a-3p in HCC and later transfected upregulated miR-27a-3p in mesenchymal stem cells, and treated HCC cells with exosomes extracted from the transfected stem cells. We then created mouse models of HCC using balbc/nude mice and equally treated them with exosomes from miR-27a-3p transfected stem cells. The results showed that miR-27a-3p is downregulated in blood, cell lines, and tissues of HCC patients compared to normal controls. Exosomes from the miR-27a-3p transfected mesenchymal stem cells prevented HCC cell proliferation, invasion, and metastasis both in vitro and in vivo. Upregulation of miR-27a-3p prevented HCC through interacting with and downregulating GOLM1 as its target oncogene. In conclusion, miR-27a-3p is a potential therapeutic target for HCC acting through GOLM1.
format Article
id doaj-art-cb625f8273f640aaab853e292fcdc7b5
institution OA Journals
issn 1687-9678
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-cb625f8273f640aaab853e292fcdc7b52025-08-20T02:19:47ZengWileyStem Cells International1687-96782022-01-01202210.1155/2022/9748714Exosomes Derived from microRNA-27a-3p Overexpressing Mesenchymal Stem Cells Inhibit the Progression of Liver Cancer through Suppression of Golgi Membrane Protein 1Christian Cedric Bongolo0Erick Thokerunga1Qian Yan2Mohamed Bassirou Moukeila Yacouba3Chao Wang4Wuhan Sheba Precision Medical Technology Co. Ltd.Department & Program of Clinical Laboratory MedicineWuhan Sheba Precision Medical Technology Co. Ltd.Department of AnesthesiologyDepartment of General SurgeryHepatocellular carcinoma (HCC) remains a significant health burden to date. Its early diagnosis and treatment are complicated by the lack of early diagnosis markers and multidrug resistance. microRNA regulation of HCC oncogenes are among the new diagnostic and therapeutic strategies being explored, although the mode of delivery of a therapeutic dose of the miRNA remains a challenge. In this study, we explored the use of exosomes from umbilical mesenchymal stem cells transfected with miR-27a-3p to interact with the oncogene GOLM1 in HCC and inhibit HCC progression both in vitro and in vivo. We first determined and compared the expression levels of miR-27a-3p in blood, various cell lines and tissues of HCC and their corresponding normal controls. We then employed bioinformatics analysis to determine the gene target for miR-27a-3p in HCC and later transfected upregulated miR-27a-3p in mesenchymal stem cells, and treated HCC cells with exosomes extracted from the transfected stem cells. We then created mouse models of HCC using balbc/nude mice and equally treated them with exosomes from miR-27a-3p transfected stem cells. The results showed that miR-27a-3p is downregulated in blood, cell lines, and tissues of HCC patients compared to normal controls. Exosomes from the miR-27a-3p transfected mesenchymal stem cells prevented HCC cell proliferation, invasion, and metastasis both in vitro and in vivo. Upregulation of miR-27a-3p prevented HCC through interacting with and downregulating GOLM1 as its target oncogene. In conclusion, miR-27a-3p is a potential therapeutic target for HCC acting through GOLM1.http://dx.doi.org/10.1155/2022/9748714
spellingShingle Christian Cedric Bongolo
Erick Thokerunga
Qian Yan
Mohamed Bassirou Moukeila Yacouba
Chao Wang
Exosomes Derived from microRNA-27a-3p Overexpressing Mesenchymal Stem Cells Inhibit the Progression of Liver Cancer through Suppression of Golgi Membrane Protein 1
Stem Cells International
title Exosomes Derived from microRNA-27a-3p Overexpressing Mesenchymal Stem Cells Inhibit the Progression of Liver Cancer through Suppression of Golgi Membrane Protein 1
title_full Exosomes Derived from microRNA-27a-3p Overexpressing Mesenchymal Stem Cells Inhibit the Progression of Liver Cancer through Suppression of Golgi Membrane Protein 1
title_fullStr Exosomes Derived from microRNA-27a-3p Overexpressing Mesenchymal Stem Cells Inhibit the Progression of Liver Cancer through Suppression of Golgi Membrane Protein 1
title_full_unstemmed Exosomes Derived from microRNA-27a-3p Overexpressing Mesenchymal Stem Cells Inhibit the Progression of Liver Cancer through Suppression of Golgi Membrane Protein 1
title_short Exosomes Derived from microRNA-27a-3p Overexpressing Mesenchymal Stem Cells Inhibit the Progression of Liver Cancer through Suppression of Golgi Membrane Protein 1
title_sort exosomes derived from microrna 27a 3p overexpressing mesenchymal stem cells inhibit the progression of liver cancer through suppression of golgi membrane protein 1
url http://dx.doi.org/10.1155/2022/9748714
work_keys_str_mv AT christiancedricbongolo exosomesderivedfrommicrorna27a3poverexpressingmesenchymalstemcellsinhibittheprogressionoflivercancerthroughsuppressionofgolgimembraneprotein1
AT erickthokerunga exosomesderivedfrommicrorna27a3poverexpressingmesenchymalstemcellsinhibittheprogressionoflivercancerthroughsuppressionofgolgimembraneprotein1
AT qianyan exosomesderivedfrommicrorna27a3poverexpressingmesenchymalstemcellsinhibittheprogressionoflivercancerthroughsuppressionofgolgimembraneprotein1
AT mohamedbassiroumoukeilayacouba exosomesderivedfrommicrorna27a3poverexpressingmesenchymalstemcellsinhibittheprogressionoflivercancerthroughsuppressionofgolgimembraneprotein1
AT chaowang exosomesderivedfrommicrorna27a3poverexpressingmesenchymalstemcellsinhibittheprogressionoflivercancerthroughsuppressionofgolgimembraneprotein1